Poland· PL-100193480
Lacidofil
A antidiarrheal microorganisms product containing lacticaseibacillus rhamnosus r0011 + lactobacillus helveticus r0052, registered in Poland by LALLEMAND S.A.S.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lacticaseibacillus rhamnosus r0011 + lactobacillus helveticus r0052 is registered in 4 of 19 countries.
Countries holding a registration under ATC A07FA (antidiarrheal microorganisms), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Lacticaseibacillus rhamnosus r0011 + lactobacillus helveticus r0052 · ATC A07FA
4 / 19 countries
- Finlandprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Lacticaseibacillus rhamnosus R0011 + Lactobacillus helveticus R0052
- Manufacturer
- LALLEMAND S.A.S.
- Country
- Poland (PL)
- ATC code
- A07FA
- ATC class
- Antidiarrheal microorganisms
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909990235018
- gtin05909990235063
- gtin05909990235070
- gtin05909990235025
- gtin05909990235087
- gtin05909990235032
- gtin05909990235049
- gtin05909990235056
- gtin05909990615964
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A07FA
Antidiarrheal microorganisms, as other registers publish it.
- PolandEnterolBIOCODEX
- PolandEnterolBIOCODEX
- United StatesGUNA-KIDNEYGuna spa
- PolandLacteol Fort 340 mgDSM-Firmenich Houdan SAS
- PolandLacteol Fort 340 mgDSM-Firmenich Houdan SAS
- PolandLakcidZakłady Farmaceutyczne POLPHARMA S.A.
- PolandLakcidZakłady Farmaceutyczne POLPHARMA S.A.
- PolandLakcid forteZakłady Farmaceutyczne POLPHARMA S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3651a67-4423-4559-9c90-3b1ed7d6fac4 GET /v1/drugs/f3651a67-4423-4559-9c90-3b1ed7d6fac4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "2 x 10^9 CFU",
"packaging": "05909990235018 ¦ OTC ¦ 5610\n20 kaps.\n05909990235063 ¦ OTC ¦ Skasowane ¦ 5611\n30 kaps. w butelce ze szkła\n05909990235070 ¦ OTC ¦ Skasowane ¦ 5612\n75 kaps. w butelce ze szkła\n05909990235025 ¦ OTC ¦ 5613\n200 kaps.\n05909990235087 ¦ Lz ¦ Skasowane ¦ 5614\n1500 kaps. w butelce ze szkła\n05909990235032 ¦ OTC ¦ Skasowane ¦ 16343\n30 kaps. w butelce z plastiku\n05909990235049 ¦ OTC ¦ Skasowane ¦ 16344\n75 kaps. w butelce z plastiku\n05909990235056 ¦ Lz ¦ Skasowane ¦ 16345\n1500 kaps. w butelce z plastiku\n05909990615964 ¦ OTC ¦ 43335\n60 kaps.",
"substance": "Lacticaseibacillus rhamnosus R0011 10^9 CFU + Lactobacillus helveticus R0052 10^9 CFU",
"common_name": "Lacticaseibacillus rhamnosus R0011 + Lactobacillus helveticus R0052",
"pl_product_id": "100193480",
"pozwolenie_nr": "02350",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about lacticaseibacillus rhamnosus r0011 + lactobacillus helveticus r0052.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.